TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) has provided an announcement.
Extrawell Pharmaceutical Holdings Limited has issued a profit warning, indicating an expected loss between HK$450 million and HK$480 million for the six months ending September 30, 2025, compared to a profit in the same period in 2024. This anticipated loss is primarily due to an unrealized loss on the fair value of investments in convertible bonds, despite steady performance in its operating segments. The interim results are yet to be confirmed and will be published by the end of November 2025.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is involved in various segments, including the production of generic drugs and healthcare products, with a market focus on Hong Kong and potentially broader regions.
Average Trading Volume: 2,893,387
Technical Sentiment Signal: Buy
Current Market Cap: HK$221.8M
For detailed information about 0858 stock, go to TipRanks’ Stock Analysis page.